Results consistent with pre-clinical studies demonstrating that, in the early stages of the neurodegenerative process, disease progression in the ...
ProMIS Neurosciences Inc., a clinical-stage biotechnology firm, announced its plan to present preclinical data on novel computationally-derived vaccines targeting neurodegenerative diseases at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results